RAPID REVIEW PROTOCOL RESOURCE

Rapid Review Protocol Template

Document stakeholder priorities, time-saving adaptations, search limits, screening methods, synthesis choices, and certainty implications without hiding methodological shortcuts.

Build Your Protocol Foundation →
Explore the 13-Course Meta-Journey
Practical methodology resourceBy Dr. Esmaeel Saeedy RobatEvidence checked: 9 August 2026

A rapid-review protocol should show what you are accelerating, why you are accelerating it, and what that choice may cost. Current Cochrane guidance describes rapid review as evidence synthesis in which planning, conduct or reporting of a conventional structured review is accelerated by simplifying or omitting methods that authors must define clearly. The latest evidence-synthesis taxonomy also treats rapid review as a mode that can be applied to different underlying synthesis types rather than as one fixed recipe.1,2

That distinction changes what a useful protocol needs to record. A generic systematic-review protocol tells readers what the team plans to do. A rapid-review protocol must also identify each deliberate restriction, the decision pressure behind it, the safeguard used to reduce avoidable error, and the limitation that remains after mitigation. The purpose is not to prove that the accelerated method is equivalent to a full review. It is to make the trade-off visible before results are known.2,3

Scope of this tool. The deepest operational guidance below is for rapid systematic reviews of effectiveness, because the 2024 Cochrane recommendations are explicitly written for that setting. The tool also supports rapid scoping reviews and rapid qualitative evidence syntheses at the level of adaptation logging, but it changes or disables fields that do not belong to those designs. Specialist rapid diagnostic, prognostic, economic and other syntheses should use design-specific methodological guidance in addition to this protocol.2,11,12

The deadline is not the protocol

Rapid reviews are often commissioned because evidence is needed before a policy, guideline, reimbursement or service decision. The appropriateness literature asks teams to weigh urgency, the consequences of waiting, the likely use of the findings, scope, available expertise and resources. It does not define a rapid review by a universal number of weeks or months. A student deadline, publication target or wish to reduce workload may be real constraints, but they do not by themselves establish a decision need that justifies methodological abbreviation.3,20

Rapid review adaptation chain Five aligned stages show a defensible rapid-review decision chain from the decision need to the deadline, method adaptation, mitigation and audit trail. 1. Decision need What decisioncannot wait? 2. Deadline What must beready, and when? 3. Adaptation Which method isrestricted? 4. Safeguard How will errorbe reduced? 5. Audit What remainslimited? A defensible rapid protocol links every restriction to a reason, a safeguard and a limitation.
Figure 1. Rapid conduct is defensible when the methodological trade-off is explicit. The protocol should preserve the chain from decision need to residual limitation rather than recording only the shortcut.

Rapid does not mean abbreviated at every step

The 2024 Cochrane guidance contains 24 recommendations for rapid reviews of effectiveness and explicitly states that teams may apply all or some proposed restrictions according to the topic, timeframe and resources. Several core safeguards are retained in abbreviated form. Search planning still needs expertise. Risk-of-bias assessment is not automatically dropped. Meta-analysis remains appropriate when data can be pooled and resources permit. Full GRADE is recommended when time and resources allow, with narrower outcome coverage and single-reviewer assessment plus verification as possible accelerations when full implementation is infeasible.2,4,7,8

Review stepPossible accelerationWhat current evidence saysProtocol safeguard
Literature searchUse a smaller set of high-yield sources or narrower supplementary searching.Rapid-search guidance recommends selecting a small number of relevant sources and optimizing precision and sensitivity; the exact source set depends on the question.4Name the omitted source/search method and explain why the retained set is likely to capture decision-relevant evidence.
Title/abstract screeningCalibrate dual screening on a proportion, then move to single screening if agreement is good.Cochrane gives 20% and κ≈0.8 as examples within this recommendation, not universal validation thresholds.2 A separate randomized study found single-reviewer abstract screening missed 13% of relevant studies in its test setting.6State the calibration plan, agreement rule, reviewer experience and how exclusions will be checked.
Data extractionOne reviewer extracts a minimal required dataset; a second verifies.This is part of current rapid-review methods guidance and is safer than unverified single extraction.5Define which data receive full verification, especially effect estimates and critical outcomes.
Risk of biasOne reviewer assesses; a second verifies; outcome-level assessment may focus on decision-critical outcomes.Current effectiveness-review guidance retains risk-of-bias assessment rather than treating omission as a default shortcut.2,5Record tool, outcome scope, reviewer model and verification.
CertaintyPrioritize the main intervention/comparator and critical outcomes; use one rater plus verifier.Full GRADE is recommended if time and resources allow; abbreviated application should remain transparent.7Explain what was not graded and why that matters for decision use.
SynthesisLimit secondary analyses rather than assuming meta-analysis must be removed.Rapid-review guidance says to consider meta-analysis when appropriate and resources permit; systematic-review standards still apply.2,8Prespecify the minimum synthesis needed to answer the decision question.
Retain, adapt and explain rapid review methods Six review steps are arranged in rows against three aligned columns: retain the standard method, adapt with a safeguard, and explain the residual limitation. Review stepRetain or adapt deliberatelyExplain what remains uncertain SearchFewer high-yield sources, justifiedPotential evidence not retrieved ScreeningCalibration + single reviewerGreater false-exclusion risk ExtractionOne extractor + verifierResidual extraction error AppraisalOne assessor + verificationLess redundancy in judgement SynthesisKeep the analysis neededfor the questionReduced secondary analyses CertaintyFocus critical outcomes if neededDecision confidence may be less complete
Figure 2. The protocol should not reward the number of shortcuts. For each review step, the team can retain the standard method or record a justified acceleration and the limitation that remains after mitigation.

Build the rapid-review protocol

The builder below is an orientation and documentation tool, not a validation instrument. It does not calculate a rapid-review quality score. It stores entered text only in your browser when you choose Save locally; nothing is transmitted to MetaSyn Academy.

Rapid-review protocol builder

Define the decision need first. Then document only the adaptations you actually plan to use.

1. Review identity and underlying design
Rapid is the conduct mode. The underlying design controls which methods, appraisal tools and synthesis standards apply.1,11,12
2. Decision-maker, decision and timeline
Do not use a short timeline alone as the justification. Record the decision that cannot reasonably wait, the cost of delay and whether the scope can be made methodologically feasible.3
3. Scope restrictions introduced for speed

Record only restrictions introduced because of the rapid timeline. Ordinary eligibility decisions belong in the underlying review protocol.

Avoid arbitrary recency rules such as “last five years.” Date or language restrictions need a topic-specific rationale and should be carried forward as explicit limitations. Evidence about the consequences of such restrictions is context-dependent.4,18
4. Methodological adaptation matrix

For every step, “Retain standard method” is a legitimate rapid-review choice. Use the rationale, consequence and mitigation fields only when you abbreviate the method.

S

Search

Decision required
1

Study selection / screening

Decision required
2

Data extraction / charting

Decision required
3

Critical appraisal / risk of bias

Design-dependent
4

Synthesis

Question-dependent
Rapid review is not synonymous with narrative-only synthesis. Cochrane recommends considering meta-analysis when appropriate and resources permit.2,8
5

Certainty / confidence in findings

Design-dependent
5. Governance and knowledge-user involvement
Commissioning does not remove methodological responsibility. Knowledge-user guidance encourages meaningful involvement because rapid reviews are intended for time-sensitive decisions, but involvement is not a universal definitional prerequisite. Record who defines the decision need and who evaluates whether a proposed shortcut remains defensible.9
6. Supportive software, automation and AI
7. Registration and public protocol route
PROSPERO eligibility follows the underlying review architecture and stage, not the word “rapid.” Its current policy does not accept scoping reviews and does not accept systematic reviews that have started data extraction.17
8. Prospective limitation forecast
9. Future reporting readiness

This is a prospective preparation check, not a PRISMA-RR compliance score. PRISMA-RR remains under development. The published interim rapid-review reporting guidance supplements existing reporting standards while that work continues.13,16

10. Protocol deviations log

Leave this blank at protocol finalization. Add a row whenever an executed method differs from the prospective plan.

DateReview stepProtocol planExecuted methodReason and consequence
No protocol data are sent from this page.

What this template cannot decide for you

No protocol template can establish that a chosen shortcut has a known amount of bias. For several common restrictions, direct empirical estimates of time saved or evidence lost remain sparse or context-dependent. Even the frequently cited 13% missed-study result comes from a particular randomized screening experiment, not from every topic, reviewer or software environment.6,19 Use empirical estimates to understand the direction of the trade-off, not to manufacture a universal risk score.

The template also does not convert Cochrane’s effectiveness-review recommendations into universal rules for every rapid synthesis. Rapid scoping and mapping reviews now have dedicated guidance, and rapid qualitative evidence synthesis has its own methods guidance. A rapid overview adds review-level appraisal, currency and overlap problems that need specialist planning. The safest workflow is to identify the underlying synthesis design first and then decide which accelerations belong to that design.11,12

The protocol should make speed auditable

A rapid review becomes interpretable when the reader can reconstruct the trade-off. Which decision had to be supported? Which standard methods were retained? Which were changed? Was the change supported by methods guidance or simply imposed by the deadline? What verification remained? What evidence might have been missed or judged with less redundancy? What changed after the protocol?

That is the job of this template. It does not reward a review for being fast. It records the methodological price of being fast so that reviewers, commissioners and readers can judge whether the resulting evidence is fit for the decision it was built to support.

Read the rapid-review planning guideUnderstand how search, screening, extraction, appraisal and certainty trade-offs should be interpreted rather than merely recorded.Recheck the underlying synthesis designReturn to the evidence-synthesis design hub if the question may require scoping, overview, qualitative or another specialist method.Develop the detailed searchMove from protocol-level search restrictions into reproducible information-source and search-strategy development.

Keep the rapid plan connected to the full protocol logic

If the review question, eligibility framework or analysis plan is still unstable, resolve those foundations before adding more shortcuts. Rapid methods work best when acceleration is applied to an already coherent review design.

Build protocol-planning skills in Course 1 →

Get every MetaSyn template free, including this one.

Leave your email and I’ll send this resource as an editable Word file and a printable PDF, plus access to the smart online version. You’ll also get every new template as it’s finished. No noise, just the resources.

Methodological scope note. The Cochrane 2024 recommendation set cited here is specifically written for rapid reviews of effectiveness. Rapid scoping, mapping and qualitative evidence syntheses now have separate methods guidance. The template therefore uses design-conditional fields rather than treating every Cochrane effectiveness recommendation as universal rapid-review law.

References

  1. Nussbaumer-Streit B, Campbell F, Munn Z, et al. Overview of evidence synthesis types and modes. J Clin Epidemiol. 2025;187:111970. https://doi.org/10.1016/j.jclinepi.2025.111970
  2. Garritty C, Hamel C, Trivella M, et al. Updated recommendations for the Cochrane rapid review methods guidance for rapid reviews of effectiveness. BMJ. 2024;384:e076335. https://doi.org/10.1136/bmj-2023-076335
  3. Garritty C, Nussbaumer-Streit B, Hamel C, Devane D; Cochrane Rapid Reviews Methods Group. Rapid reviews methods series: assessing the appropriateness of conducting a rapid review. BMJ Evid Based Med. 2025;30(1):55-60. https://doi.org/10.1136/bmjebm-2023-112722
  4. Klerings I, Robalino S, Booth A, et al.; Cochrane Rapid Reviews Methods Group. Rapid reviews methods series: guidance on literature search. BMJ Evid Based Med. 2023;28(6):412-417. https://doi.org/10.1136/bmjebm-2022-112079
  5. Nussbaumer-Streit B, Sommer I, Hamel C, et al.; Cochrane Rapid Reviews Methods Group. Rapid reviews methods series: guidance on team considerations, study selection, data extraction and risk of bias assessment. BMJ Evid Based Med. 2023;28(6):418-423. https://doi.org/10.1136/bmjebm-2022-112185
  6. Gartlehner G, Affengruber L, Titscher V, Noel-Storr A, Dooley G, Ballarini N, König F. Single-reviewer abstract screening missed 13 percent of relevant studies: a crowd-based, randomized controlled trial. J Clin Epidemiol. 2020;121:20-28. https://doi.org/10.1016/j.jclinepi.2020.01.005
  7. Gartlehner G, Nussbaumer-Streit B, Devane D, et al.; Cochrane Rapid Reviews Methods Group. Rapid reviews methods series: guidance on assessing the certainty of evidence in rapid reviews. BMJ Evid Based Med. 2024;29(1):50-54. https://doi.org/10.1136/bmjebm-2022-112111
  8. King VJ, Nussbaumer-Streit B, Shaw E, et al.; Cochrane Rapid Reviews Methods Group. Rapid reviews methods series: considerations and recommendations for evidence synthesis in rapid reviews. BMJ Evid Based Med. 2024;29(6):419-422. https://doi.org/10.1136/bmjebm-2023-112617
  9. Garritty C, Tricco AC, Smith M, et al.; Cochrane Rapid Reviews Methods Group. Rapid Reviews Methods Series: involving patient and public partners, healthcare providers and policymakers as knowledge users. BMJ Evid Based Med. 2024;29(1):55-61. https://doi.org/10.1136/bmjebm-2022-112070
  10. Affengruber L, Nussbaumer-Streit B, Hamel C, et al.; Cochrane Rapid Reviews Methods Group. Rapid review methods series: guidance on the use of supportive software. BMJ Evid Based Med. 2024;29(4):264-271. https://doi.org/10.1136/bmjebm-2023-112530
  11. Campbell F, Sutton A, Pollock D, et al. Rapid reviews methods series: guidance on rapid scoping, mapping and evidence and gap map (‘Big Picture Reviews’). BMJ Evid Based Med. 2025;30(4):268-277. https://doi.org/10.1136/bmjebm-2023-112389
  12. Booth A, Noyes J, Flemming K, et al. Rapid reviews methods series: guidance on rapid qualitative evidence synthesis. BMJ Evid Based Med. 2024;29(3):194-200. https://doi.org/10.1136/bmjebm-2023-112620
  13. Stevens A, Hersi M, Garritty C, et al.; Cochrane Rapid Reviews Methods Group. Rapid review method series: interim guidance for the reporting of rapid reviews. BMJ Evid Based Med. 2025;30(2):118-123. Published online 2024. https://doi.org/10.1136/bmjebm-2024-112899
  14. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71
  15. Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350:g7647. https://doi.org/10.1136/bmj.g7647
  16. EQUATOR Network. Reporting guidelines under development for systematic reviews: PRISMA-RR and PRISMA-P update records. Status checked 9 August 2026. EQUATOR under-development register.
  17. Centre for Reviews and Dissemination, University of York. PROSPERO: eligibility for inclusion. Status checked 9 August 2026. PROSPERO eligibility.
  18. Nussbaumer-Streit B, Klerings I, Dobrescu AI, et al. Excluding non-English publications from evidence-syntheses did not change conclusions: a meta-epidemiological study. J Clin Epidemiol. 2020;118:42-54. https://doi.org/10.1016/j.jclinepi.2019.10.011
  19. Haby MM, Barreto JOM, Kim JYH, et al. What are the best methods for rapid reviews of the research evidence? A systematic review of reviews and primary studies. Res Synth Methods. 2024;15:2-20. https://doi.org/10.1002/jrsm.1664
  20. Hamel C, Michaud A, Thuku M, et al. Defining rapid reviews: a systematic scoping review and thematic analysis of definitions and defining characteristics of rapid reviews. J Clin Epidemiol. 2021;129:74-85. https://doi.org/10.1016/j.jclinepi.2020.09.041

Rapid review protocol questions

Is a rapid review defined by finishing within six months?

No. Time pressure is characteristic of rapid reviews, but current methods guidance does not define the method solely by a universal duration. Record the actual decision deadline and the methodological adaptations used to meet it.3,20

Do I have to abbreviate every review step?

No. Cochrane explicitly allows teams to apply all or some restrictions according to the topic, timeframe and resources. Retaining a standard method is often the safest rapid-review decision.2

Must I use exactly 20% dual screening and κ≥0.8?

No universal validation rule should be inferred from those numbers. Cochrane uses a proportion such as 20% and agreement such as κ≈0.8 as examples in its recommendation to calibrate partial dual screening before moving to single screening.2

Can a rapid review use meta-analysis?

Yes. When studies are appropriate to pool and resources permit, the same standards for meta-analysis used in a systematic review apply to the rapid review.2,8

Can I omit risk-of-bias assessment to save time?

Not as the default for a rapid effectiveness review. Current Cochrane guidance retains appraisal and recommends one assessor with a second person verifying judgments as an accelerated staffing model.2,5 Other underlying designs, such as rapid scoping reviews, follow their own appraisal logic.

Is full GRADE mandatory in every rapid review?

No. For rapid effectiveness reviews, full GRADE is recommended if time and resources allow. If full implementation is not feasible, current guidance describes ways to focus the assessment on critical outcomes and streamline reviewer staffing.7

Does PROSPERO accept every rapid review?

No. Eligibility follows the underlying review type and PROSPERO policy. The registry currently excludes scoping reviews and systematic reviews that have already started data extraction.17

Is PRISMA-RR finalized?

No finalized PRISMA-RR checklist is publicly available as of 9 August 2026. The EQUATOR record still lists the extension as under development. Published interim rapid-review reporting guidance should be kept separate from the unfinished PRISMA extension.13,16

Citation numbering is synchronized with the superscript links in the main resource block. If Rank Math already emits equivalent WebPage, FAQ or breadcrumb entities, disable duplicates rather than publishing parallel schema graphs.